G. Montini, K. Tullus, and I. Hewitt, Febrile urinary tract infections in children, N Engl J Med, vol.365, pp.239-250, 2011.

S. H. Jacobson, O. Eklof, and C. G. Eriksson, Development of hypertension and uraemia after pyelonephritis in childhood: 27 year follow up, BMJ, vol.299, pp.703-706, 1989.

N. Shaikh, T. K. Mattoo, R. Keren, A. Ivanova, G. Cui et al., Early Antibiotic Treatment for Pediatric Febrile Urinary Tract Infection and Renal Scarring, JAMA Pediatr, vol.170, pp.848-854, 2016.

R. H. Hanna-wakim, S. T. Ghanem, E. Helou, M. W. Khafaja, S. A. Shaker et al., Epidemiology and characteristics of urinary tract infections in children and adolescents, Front Cell Infect Microbiol, vol.5, p.45, 2015.

J. J. Zorc, D. A. Kiddoo, and K. N. Shaw, Diagnosis and management of pediatric urinary tract infections, Clin Microbiol Rev, vol.18, pp.417-422, 2005.

J. D. Pitout and K. B. Laupland, Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern, Lancet Infect Dis, vol.8, pp.70041-70041, 2008.

G. Livni and S. Ashkenazi, Treatment of resistant bacterial infections in children: thinking inside and outside the box, Adv Exp Med Biol, vol.764, pp.123-132, 2013.

J. Rodriguez-bano, J. C. Alcala, J. M. Cisneros, F. Grill, A. Oliver et al., Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli, Arch Intern Med, vol.168, pp.1897-1902, 2008.

A. Apisarnthanarak, P. Kirastisin, and L. M. Mundy, Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae, Infect Control Hosp Epidemiol, vol.29, pp.671-674, 2008.

P. M. Den-reijer, S. Van-burgh, A. Burggraaf, J. M. Ossewaarde, and A. Van-der-zee, The Widespread Presence of a Multidrug-Resistant Escherichia coli ST131 Clade among Community-Associated and Hospitalized Patients, PLoS One, vol.11, issue.0150420, 2016.

L. Falgenhauer, C. Imirzalioglu, H. Ghosh, K. Gwozdzinski, J. Schmiedel et al., Circulation of clonal populations of fluoroquinolone-resistant CTX-M-15-producing Escherichia coli ST410 in humans and animals in Germany, Int J Antimicrob Agents, vol.47, pp.457-465, 2016.

, Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months, Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management, Roberts KB, vol.128, pp.595-610, 2011.

R. Mori, M. Lakhanpaul, and K. Verrier-jones, Diagnosis and management of urinary tract infection in children: summary of NICE guidance, BMJ, vol.335, pp.395-397, 2007.

L. Armand-lefèvre, C. Angebault, F. Barbier, E. Hamelet, G. Defrance et al., Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother, vol.57, pp.1488-1495, 2013.

P. Mcgann, E. Snesrud, R. Maybank, B. Corey, A. C. Ong et al., Escherichia coli Harboring mcr-1 and blaCTX-M on a Novel IncF Plasmid: First Report of mcr-1 in the United States, vol.60, pp.4420-4421, 2016.

B. Pilmis, T. Delory, M. Groh, E. Weiss, A. Emirian et al., Extended-spectrum beta-lactamaseproducing Enterobacteriaceae (ESBL-PE) infections: are carbapenem alternatives achievable in daily practice?, Int Infect Dis, vol.39, pp.62-67, 2015.

R. Cohen, J. Raymond, F. A. Gillet, Y. Grimprel, and E. ,

. Société-de-pathologie-infectieuse-de-langue-française, Management of urinary tract infections in children. Recommendations of the Pediatric Infectious Diseases Group of the French Pediatrics Society and the French-Language Infectious Diseases Society, Arch Pediatr, vol.22, pp.665-671, 2015.

. Afssaps, Diagnostic et antibiothérapie des infections urinaires bactériennes communautaires du nourrisson et de l'enfant, 2007.

R. Stein, H. S. Dogan, P. Hoebeke, R. Ko?vara, R. J. Nijman et al., Urinary tract infections in children: EAU/ESPU guidelines, Eur Urol, vol.67, pp.546-558, 2015.

O. Megged, Extended-spectrum ?-lactamase-producing bacteria causing community-acquired urinary tract infections in children, Pediatr Nephrol, vol.29, p.24705795, 2014.

A. Birgy, R. Cohen, C. Levy, P. Bidet, C. Courroux et al., Community faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in French children, BMC Infect Dis, vol.12, p.315, 2012.

, Recommandations du comité de l'antibiogramme de la société française de microbiologie, 2014.

L. Drieux, F. Brossier, W. Sougakoff, and V. Jarlier, Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide, Clin Microbiol Infect, vol.14, pp.90-103, 2008.

E. Bingen, P. Bidet, A. Birgy, E. Sobral, P. Mariani et al., In vitro interaction between cefixime and amoxicillin-clavulanate against extended-spectrum-betalactamase-producing Escherichia coli causing urinary tract infection, J Clin Microbiol, vol.50, pp.2540-2541, 2012.

W. A. Craig, Optimizing aminoglycoside use, Crit Care Clin, vol.27, pp.107-121, 2011.

S. B. Han, S. C. Lee, S. Y. Lee, D. C. Jeong, and J. H. Kang, Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum ?-lactamase-producing Escherichia coli or Klebsiella pneumoniae, BMC Infect Dis, vol.15, p.26464143, 2015.

N. Poey, F. Madhi, S. Biscardi, S. Béchet, and R. Cohen, Aminoglycosides Monotherapy as First-Line Treatment for Febrile Urinary Tract Infection in Children, Pediatr Infect Dis. J, 2017.

, Mise au point sur le bon usage des aminosides administrés par voie injectable : gentamicine, tobramycine, nétilmicine, amikacine, ANSM (Agence nationale de sécurité du médicament et des produits de santé), 2011.

S. K. Bouchillon, R. E. Badal, D. J. Hoban, and S. P. Hawser, Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011, Clin Ther, vol.35, pp.872-877, 2013.

M. F. Wolf and A. Simon, The use of piperacillin-tazobactam in neonatal and paediatric patients, Expert Opin Drug Metab Toxicol, vol.5, pp.57-69, 2009.

T. M. Ng, W. X. Khong, P. N. Harris, P. P. De, A. Chow et al., Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae, Plos One, vol.11, 2016.

D. M. Livermore and P. M. Tulkens, Temocillin revived, J Antimicrob Chemother, vol.63, pp.243-245, 2009.

J. F. Soubirou, B. Rossi, C. Couffignal, E. Ruppé, F. Chau et al., Activity of temocillin in a murine model of urinary tract infection due to

, J Antimicrob Chemother, vol.70, pp.1466-1472, 2015.

M. E. Falagas, E. K. Vouloumanou, and A. G. Togias, Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials, J Antimicrobial Chemother, vol.65, pp.1862-1877, 2010.

G. V. Sanchez, A. Baird, and J. A. Karlowsky, Nitrofirantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients, J Antimicrob Chemother, vol.69, pp.3259-3262, 2014.

P. D. Tamma and J. Rodriguez-bano, The Use of Noncarbapenem ?-Lactams for the Treatment of Extended-Spectrum ?-Lactamase Infections, Clin Infect Dis, vol.64, pp.972-980, 2017.

H. Wright, R. A. Bonomo, and D. L. Paterson, New agents for the treatment of infections with Gram-negative bacteria: restoring the miracle or false dawn?, Clin Microbiol Infect, 2017.

E. Bingen, P. Bidet, A. Birgy, E. Sobral, P. Mariani et al., In vitro interaction between cefixime and amoxicillin-clavulanate against extended-spectrum-beta-lactamase-producing Escherichia coli causing urinary tract infection, J Clin Microbiol, vol.50, pp.2540-2541, 2012.

F. Madhi, S. Biscardi, E. Bingen, O. Jaby, R. Epaud et al., Combined relay therapy with oral cefixime and clavulanate for febrile urinary tract infection caused by extended-spectrum ?-lactamase-producing Escherichia coli, Pediatr Infect Dis J, vol.32, pp.96-97, 2013.

I. Greenhouse, F. Babushkin, T. Finn, Z. Shimoni, M. Aliman et al., Long-term outcomes of inappropriate antibiotic therapy for upper urinary tract infections caused by extended-spectrum betalactamase-producing Enterobacteriaceae: a retrospective cohort study, Diagn Microbiol Infect Dis, 2017.

A. Tratselas, M. Simitsopoulou, A. Giannakopoulou, I. Dori, S. Saoulidis et al., Effect of ceftriaxone on the outcome of murine pyelonephritis caused by extended-spectrum-?-lactamase-producing Escherichia coli, Antimicrob Agents Chemother, vol.58, pp.3974-3988, 2014.

R. J. Drew, E. E. Ormandy, K. Ball, S. E. Lambert, S. Paulus et al., Antimicrobial Susceptibility Patterns Among Extended-Spectrum ?-Lactamase-Producing Enterobacteriaceae in a Large Pediatric Hospital in the United Kingdom, J Pediatric Infect Dis Soc, vol.4, pp.147-150, 2015.

S. H. Lob, L. E. Nicolle, D. J. Hoban, K. M. Kazmierczak, R. E. Badal et al., Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, Diagn Microbiol Infect Dis, vol.85, pp.459-465, 2016.

F. Robin, R. Beyrouthy, S. Bonacorsi, N. Aissa, L. Bret et al., Inventory of Extended-Spectrum-?-Lactamase-Producing Enterobacteriaceae in France as Assessed by a Multicenter Study, Antimicrob Agents Chemother, issue.3, p.61, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01595458

N. Uyar-aksu, Z. Ekinci, D. Dündar, and C. Baydemir, Childhood urinary tract infection caused by extendedspectrum ?-lactamase-producing bacteria: Risk factors and empiric therapy, Pediatr Int, vol.59, pp.176-180, 2017.

J. Toubiana, S. Timsit, A. Ferroni, M. Grasseau, X. Nassif et al., Community-Onset Extended-Spectrum ?-Lactamase-Producing Enterobacteriaceae Invasive Infections in Children in a University Hospital in France, Medicine (Baltimore), vol.95, p.3163, 2016.

M. E. Flokas, M. Detsis, M. Alevizakos, and E. Mylonakis, Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections: A systematic review and meta-analysis, J Infect, 2016.

A. Carbonne, I. Arnaud, S. Maugat, N. Marty, C. Dumartin et al., National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience, J Antimicrobio Chemother, vol.68, pp.954-959, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00802748

A. Gervaix, A. Galetto-lacour, T. Gueron, L. Vadas, S. Zamora et al., Usefulness of procalcitonin and C-reactive protein rapid tests for the management of children with urinary tract infection, Pediatr Infect Dis J, vol.20, pp.507-511, 2001.